A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants
Status:
Completed
Trial end date:
2021-01-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two different formulations of mirikizumab in healthy
participants. This study will compare how much of each formulation gets into the blood stream
and how long it takes the body to remove it. Information about any side effects that may
occur will also be collected. Participants will remain in the study for about 12 weeks, after
receiving study drug.